0001209191-19-003552.txt : 20190114
0001209191-19-003552.hdr.sgml : 20190114
20190114163535
ACCESSION NUMBER: 0001209191-19-003552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190111
FILED AS OF DATE: 20190114
DATE AS OF CHANGE: 20190114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Pritesh
CENTRAL INDEX KEY: 0001744884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19525380
MAIL ADDRESS:
STREET 1: C/O NOVOCURE INC.
STREET 2: 20 VALLEY STREAM PARKWAY, SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-11
0
0001645113
NovoCure Ltd
NVCR
0001744884
Shah Pritesh
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2019-01-11
4
M
0
8751
14.37
A
25838
D
Ordinary Shares
2019-01-11
4
S
0
8751
42.004
D
17087
D
Ordinary Shares
2019-01-11
4
M
0
17500
11.46
A
34587
D
Ordinary Shares
2019-01-11
4
S
0
17500
42.004
D
17087
D
Options to Buy Ordinary Shares
14.37
2019-01-11
4
M
0
8751
0.00
D
2025-02-23
Ordinary Shares
8751
0
D
Options to Buy Ordinary Shares
11.46
2019-01-11
4
M
0
17500
0.00
D
2026-02-24
Ordinary Shares
17500
7463
D
Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.
On January 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 8,751 shares in multiple trades at prices ranging from $42.00 to $42.03. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 17,500 shares in multiple trades at prices ranging from $42.00 to $42.03. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Options exercised were fully vested as of the date hereof.
/s/ Kimberly Burke, Attorney in fact for Pritesh Shah
2019-01-14